Hem › Steatotisk leversjukdom › Texas › Dallas
Kliniska studier för Steatotisk leversjukdom i Dallas, TX
9 studier för Steatotisk leversjukdom söker deltagare vid platser i och runt Dallas (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
RekryterarFas 3
- GSK Investigational Site, Dallas
A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
RekryterarFas 3
- GSK Investigational Site, Dallas
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
RekryterarFas 2
- Methodist Dallas Medical Center, Dallas
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
RekryterarFas 3
- Akero Clinical Study Site, Dallas
- Akero Clinical Study Site, Dallas
- Akero Clinical Study Site, Dallas
- och 1 fler
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
RekryterarFas 3
- GSK Investigational Site, Dallas
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
RekryterarFas 2
- GSK Investigational Site, Dallas
- GSK Investigational Site, Dallas
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
RekryterarFas 3
- GSK Investigational Site, Dallas
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
RekryterarFas 2
- GSK Investigational Site, Dallas
Exploratory Analysis of Enhanced Liver Function (ELF) Test to Detect Early Fatty Liver in High Risk Population
RekryterarObservationsstudie
- Methodist Dallas Medical Center, Dallas
Steatotisk leversjukdom-studier i andra städer
- San Antonio, TX17 studier
- New York City, NY16 studier
- Miami, FL16 studier
- San Diego, CA14 studier
- Austin, TX13 studier
- Houston, TX13 studier
- Richmond, VA12 studier
- Tucson, AZ10 studier
- Chandler, AZ10 studier
- Hialeah, FL9 studier
- Orlando, FL9 studier
- St. Louis, MO9 studier
Andra studier i Dallas
- Bröstcancer55 studier
- Icke-småcellig lungcancer52 studier
- Metastaserande cancer42 studier
- Hjärtsvikt42 studier
- Cancer (alla typer)37 studier
- Prostatacancer36 studier
- Kolorektal cancer33 studier
- Övervikt30 studier
- Äggstockscancer28 studier
- Lungcancer27 studier
- Blåscancer27 studier
- Endometriecancer24 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.